Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-09

Clinical Trial Update: Terlipressin Infusion Alone Vs Terlipressin With Noradrenaline Infusion In The Treatment of Hepatorenal Syndrome Type 1 [Phase 3]

View source ↗

Summary

Phase 3 trial comparing terlipressin infusion alone versus terlipressin with noradrenaline infusion for Type 1 hepatorenal syndrome; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Noradrenaline (noradrenaline)
  • Terlipressin (terlipressin)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Type 1 HEPATO RENAL SYNDROME(HRS) | Phase 3 | Status: COMPLETED